Cannabis News
Guess Which Liberal, Free-Wheeling State Is the First to Allow Pharmacies to Sell Cannabis Oil?
Published
1 year agoon
By
admin
Do you remember Dale Jackson, the Georgia father who invited police to follow him as he crossed state lines and got cannabis oil for his autistic son, Colin? All his hard work has paid off as Georgia familes with sick kids will now get a chance at the same cannabis oil that has helped his son so much.
The Georgia Board of Pharmacy has initiated the process of receiving applications from licensed, independent pharmacies seeking approval to distribute authorized medical marijuana products. According to an official statement from Botanical Sciences, one of the state’s two licensed production companies, approximately 120 pharmacies have already committed to dispensing medication.
This marks a significant milestone in the state’s new regulatory framework, making Georgia the pioneer in the nation to make medical marijuana products available at independent pharmacies. It’s worth noting that Georgia has over 400 such independent pharmacies.
While Georgia’s legislation prohibits the cultivation, sale, or possession of marijuana in its natural plant or leaf state, it does authorize the production, sale, and consumption of food products infused with a substance known as low THC oil. Moreover, it permits inhaling of low-THC oil through smoking, electronic vaping, or vaporization. Individuals with active low-THC oil registry cards can have up to 20 fluid ounces of low-THC oil strictly for medicinal purposes.
Notably, low THC oil is restricted to containing no more than 5% THC, the psychoactive compound responsible for inducing a “high” in users. The Georgia General Assembly endorsed the distribution of low-THC oil as part of a state law enacted in 2019.
However, it took several years to establish comprehensive regulations concerning safety, inspections, licensing, and distribution. Governor Brian Kemp recently granted approval to the rules passed by the Georgia Board of Pharmacy last month, thereby paving the way for the commencement of pharmacy sales.
Introducing medical cannabis sales in pharmacies will make low-THC oil more accessible to a broader range of patients in Georgia. This complements the seven dispensaries that have been operational since April. To purchase cannabis oil at a pharmacy, patients must present a state-issued low THC oil registry card and valid identification.
These new regulations signify an expansion of Georgia’s medical marijuana market and serve as a potential blueprint for other states considering pharmacy-based sales.
Botanical Sciences Pioneers Georgia’s Status as the First State to Offer Medical Cannabis at Independent Pharmacies
Botanical Sciences, Georgia’s primary, physician-founded, fully integrated medical cannabis provider, will now distribute its products through licensed independent pharmacies nationwide.
The inclusion of pharmacies as authorized outlets for medical cannabis, in conjunction with Botanical Sciences’ proprietary dispensaries, broadens the pathways for patients to avail themselves of the therapeutic potential of cannabis medicine.
Georgia stands as the pioneering state in the nation to permit the dispensing of medical cannabis through pharmacies to registered patients, allowing Botanical Sciences to offer relief to a greater number of individuals in need.
Gary Long, CEO of Botanical Sciences, stated that their commitment to providing hope and relief to registered patients in Georgia is deeply rooted in our medical origins. With their five self-owned dispensaries and nearly 120 exclusive independent pharmacy partners, almost 90% of the state’s population will have access to Botanical Sciences’ medical cannabis within a 30-minute reach.
They take immense pride in leading the way in Georgia and setting an example for the nation, leveraging the trust and professionalism of pharmacists to ensure equitable access for registered patients.
In the past year, Botanical Sciences has forged strong collaborations with the Georgia Board of Pharmacy, the Georgia Pharmacy Association, and the Academy of Independent Pharmacy to implement this innovative initiative effectively.
Through this well-planned expansion, patients who have received a physician’s recommendation and secured their medical cannabis card now enjoy unprecedented access to the required medicine. To find a comprehensive list of participating independent pharmacies and nearby locations, patients can visit botanicalsciences.com/locations and enter their zip code.
Furthermore, besides being accessible at licensed pharmacies statewide, Botanical Sciences launched dispensaries in Marietta and Pooler earlier this summer. Additionally, the company plans to open three more dispensaries in Stockbridge, Chamblee, and Augusta by year’s end.
The New Regulatory Regime
This set of rules and regulations pertains to licensed pharmacies and Low THC Pharmacy Dispensaries in Georgia. Here’s a summarized version of the rules:
Protection of Low THC Products and Records
-
All licensed pharmacies possessing Low THC Products must take diligent care to protect these products and associated records from loss or theft.
-
Records related to Low THC Products should be maintained as required for Dangerous Drugs under O.C.G.A. T. Ch. 16-13 and must be secured similarly.
-
Low THC Pharmacy Dispensaries must ensure that all Low THC Products are purchased from or returned to firms holding a valid permit from the Georgia Access to Medical Cannabis Commission.
-
Low THC Products should be stored in the prescription department, accessible only to authorized personnel, unless they are in compliant collection receptacles as per state and federal regulations.
-
The Georgia Drugs and Narcotics Agency (GDNA) can inspect places or premises used by Low THC Pharmacy Dispensaries concerning Low THC Products and associated records.
-
During inspections, GDNA personnel may examine, copy, remove, or inventory records and Low THC Products.
-
Those possessing Low THC Products and records are responsible for making them available for inspection.
-
After an inspection, GDNA provides a report listing deficiencies or violations and any recommendations for secure storage and handling of Low THC Products.
-
Individuals with Low THC Products and records may request an inspection, which the GDNA Director must conduct without unreasonable delay.
Prescription Department, Requirement, Supervision, and Hours Closed
-
The physical space of a Low THC Pharmacy Dispensary is the same as that of the Predicate Retail Licensee, and activities must be conducted within this space.
-
The pharmacist in charge of the Low THC Pharmacy Dispensary is the same as the one designated for the Predicate Retail Licensee and is subject to relevant rules.
-
A licensed pharmacist must be present and on duty in a Low THC Pharmacy for the same hours as required for the operation of the Predicate Retail Licensee.
In essence, these rules ensure the secure handling and supervision of Low THC Products, maintain records, and establish guidelines for Low THC Pharmacy Dispensaries in Georgia, emphasizing compliance with state regulations and safeguarding these products and records.
WHO IS DALE JACKSON, THE GEORGIA CANNABIS OIL PIONEER? READ ON..
You may like
-
Karma Koala Podcast 238: Daniel Shortt Launches New Firm With Partner Perry Salzhauer In Pacific NW
-
Trump invites former cannabis prisoner to speech, but doesn’t mention cannabis (Newsletter: February 5, 2025)
-
Buddha Chief raises vibrations at new Housing Works dispensary in NoMad
-
3 best THCA vape carts of 2025 by Leafly
-
From client to co-founder, Storz & Bickel executive on US tour to drum up cannabis business
-
UNDERSTANDING CANNABIS AND CANNABINOIDS (THC and CBD)
Cannabis News
The Rise and Fall of the Cannabis Industry
Published
3 days agoon
March 3, 2025By
admin
The Rise and Fall of the Cannabis Industry
The cannabis industry has undergone a radical transformation over the past forty years. What began as an obscure and illegal activity hidden in the shadows has blossomed into a multi-billion dollar industry that spans across multiple states and even countries. However, this evolution hasn’t come without significant growing pains. Is Trump 2.0 part of a new avenue for cannabis?
Throughout this journey, we’ve witnessed both tremendous benefits and troubling issues emerge from a complex web of factors: overregulation that strangles small businesses, persistent black market competition that undercuts legal operators, and federal government interference that creates a patchwork of contradictory policies.
Today, we’re going to explore a region that could be considered the birthplace of American cannabis culture – Humboldt County and the broader Emerald Triangle of Northern California. This legendary growing region helped put cannabis on the map long before dispensaries dotted urban landscapes and corporate cannabis became a reality.
Let’s dive into how this iconic marijuana mecca rose to prominence, flourished during the golden years, and now faces an uncertain future as the industry continues to evolve beneath the weight of legalization’s complicated aftermath.
Let’s go!
Though I’ve never personally visited Humboldt County, its reputation in cannabis culture is legendary. Those winding roads through towering redwoods and misty mountains have become almost mythical in the stories told by those who’ve made the pilgrimage to America’s most famous growing region.
The cannabis industry in Humboldt didn’t spring up overnight. It has roots stretching back to the counterculture movement of the 1960s, when idealistic young people fled urban centers in search of simpler, more authentic lives. These back-to-the-landers discovered that the region’s remote location and ideal growing conditions made it perfect for cultivating cannabis—a crop that could actually sustain their pursuit of alternative lifestyles.
What began as a means of self-sufficiency for hippie communes soon evolved into something much more substantial. According to Paul Modic’s historical account of Humboldt’s cannabis industry, the price per pound jumped from $1,000 in 1975 to a staggering $5,000 by the early ’90s. With these kinds of returns, cannabis cultivation in the Emerald Triangle transformed from a countercultural statement into a serious economic engine.
Modic refers to this economic boon as “the Green Nipple,” a colorful term suggesting how the industry nourished an entire regional economy. Growers were able to build homes, raise families, support local businesses, and create a unique culture that blended environmental consciousness with a fiercely independent spirit. During these boom years, cannabis money flowed freely through communities like Garberville, Redway, and Willits, supporting everything from hardware stores to schools.
But as with any gold rush, the good times couldn’t last forever. The passage of Proposition 215 in 1996, which legalized medical marijuana in California, marked the beginning of significant change. While seemingly a victory for cannabis advocates, it inadvertently opened the floodgates for increased production. As more people jumped into cultivation, supply increased and prices began their long, steady decline.
By the early 2010s, according to Modic, the “Green Nipple” had transformed into what he aptly calls the “Green Monkey”—were you riding it, or was it riding you? Growers had to dramatically scale up operations just to maintain their previous income levels. Where once a modest garden could support a family, now multiple light-deprivation greenhouses and larger grows became necessary.
The stress of managing larger operations brought new challenges: more workers to supervise, increased risk of crop failure from pests or mold, and the perennial challenge of finding buyers for ever-larger harvests. As Modic points out, these stresses replaced the previous concerns about “cops and helicopters,” which had “mostly disappeared from the list of stresses by then.”
Little did these growers know that the real challenges were still to come, as full legalization loomed on the horizon and would forever change the landscape they had helped create.
On November 8, 2016, California voters passed Proposition 64, legalizing recreational cannabis use throughout the state. For decades, legalization had been the rallying cry for cannabis activists, the holy grail that would end prohibition and usher in a new era of freedom and prosperity. But for many small farmers in Humboldt County, legalization would prove to be a poisoned chalice.
The promise of legalization was seductive: no more helicopter raids, no more fear of prison, and legitimate business status. What wasn’t as apparent was the bureaucratic nightmare awaiting those who chose to enter the legal market.
Modic’s account provides several telling examples of farmers who attempted to navigate the new legal landscape, only to find themselves drowning in expenses and red tape. He writes about “one grower from Salmon Creek” who went to the bank and reported, “Estelle told me it would cost $20,000 to go legal, now I’ve got $100,000 into it and it’s a big hassle, but I’m in too deep to stop and have to keep trying to finish the paperwork.”
Another farmer from Ettersburg, according to Modic, was “complaining that it had already cost him a few hundred thousand dollars to ‘come into compliance,’ he was still far from getting his license, and if he could do it all over, he wouldn’t.” Modic later observed that this once “handsome and youthful-looking” farmer was later spotted “looking old and haggard, and still struggling with his large weed farm.”
The regulatory requirements for legal operation proved to be prohibitively complex and expensive. Environmental impact reports, water rights documentation, building permits for structures that had existed for decades, application fees, consultancy costs—the list went on and on.
The California Department of Fish and Wildlife became a particular obstacle for many farmers. Modic tells the story of “a former clone dealer from Sprowel Creek” who had a property with a spring that “started and stopped on his forty acres, one of the state requirements for licensing.” Despite this seemingly perfect setup, when Fish and Wildlife examined his land, they “discovered damage from logging decades before he bought it back in the seventies, and the expensive remediation costs would be more than the land was worth.” The farmer had no choice but to dump the property “at a loss.”
Meanwhile, as small farmers struggled to navigate the regulatory labyrinth, large corporations with significant financial backing moved in. These operations could afford compliance costs and were positioned to produce cannabis at scale, driving prices even lower. The pound price, which had already fallen to around $1,000 post-medical legalization, plummeted to $500 and then to a devastating $250 after recreational legalization, according to Modic’s account.
For context, when prices were $5,000 per pound, a farmer could make a good living with just 20 pounds per year. At $250 per pound, that same farmer would need to produce 400 pounds just to maintain their income—a scale impossible for many small operations and certainly not feasible within the constraints of legal permits for small grows.
The cruel irony wasn’t lost on the community: the very plant that had enabled generations to live independently in this rural paradise was now, under legalization, becoming the instrument of their economic demise. For many, the choice became stark: attempt to operate legally and face financial ruin, continue growing illicitly with increased risk, or abandon cannabis cultivation altogether.
As Modic notes, “businesses in town have closed, the hills have emptied out, and would-be farmers who got in late and have large land payments are abandoning their land.” The promise of legalization was revealing itself to be a complex and often devastating reality for the very communities that had built California’s cannabis industry.
When California voters approved recreational cannabis, many predicted the black market would quickly fade away. After all, why would consumers take risks with illegal purchases when they could simply walk into a licensed dispensary? Why would growers continue operating in the shadows when they could run legitimate businesses?
The reality has proven far more complicated, and the black market hasn’t just survived—in many ways, it’s thrived.
Industry analysts estimate that in 2022, California’s legal cannabis market generated approximately $5.3 billion in sales—impressive until you consider that the state’s illicit market was estimated to be worth $8 billion or more. Despite legalization, the majority of cannabis consumption in California still occurs outside the regulated system.
For Humboldt farmers, the persistence of the black market presents both an opportunity and a dilemma. As Modic observes in his historical account, “Many of those who are able to stay are looking for regular jobs with which to survive in this depressed economy, as the pound price plummets to $250.” However, he also notes that “there’s still farmers with good connections growing and selling like it’s 2008, and may have a few good years left.”
This suggests a divided industry where those with established out-of-state connections can still find buyers willing to pay premium prices, especially in prohibition states where cannabis remains scarce. However, this path comes with significant risks. Federal enforcement remains a threat, especially for interstate trafficking. Furthermore, as more states legalize and develop their own cannabis industries, these out-of-state markets become increasingly competitive.
The more troubling aspect of the thriving black market is what it reveals about the legal framework California has created. When licensed businesses struggle to compete with illicit operations, it suggests fundamental flaws in the regulatory system. The excessive taxation—which can reach 40% when combining state excise tax, local taxes, and other fees—creates an insurmountable price gap between legal and illegal cannabis.
Additionally, the limited number of licensed retail outlets throughout the state means many consumers don’t have convenient access to legal cannabis. With approximately 75% of California municipalities banning cannabis businesses, vast “cannabis deserts” exist where consumers have no choice but to turn to the black market.
For Humboldt’s legal growers, this dynamic is particularly frustrating. They’ve invested heavily in compliance, only to watch their illicit competitors undercut them without consequence. Many legal operations resort to what industry insiders sometimes call “diversion”—selling a portion of their crop into the illicit market to remain financially viable.
This reality points to a broader failure in California’s approach to legalization. Rather than creating a functioning legal market that could absorb and transform existing cannabis operations, the state has inadvertently strengthened the very black market it sought to eliminate.
For Humboldt County, this means the cannabis economy continues to operate in a precarious gray zone—neither fully legal nor completely illicit, with participants forced to navigate an increasingly complex and risky landscape.
Perhaps the most important question raised by the transformation of Humboldt’s cannabis industry concerns the fate of the pioneers who built it. As Modic asks in his historical account, “What’s going to happen to all those back-to-the-landers and old growers, now in their seventies and eighties, still living in their off-grid cabins in the middle of nowhere, without the steady income they had over the last forty years, and no retirement plan?”
It’s a profound question that highlights the human cost of this industrial transformation. For decades, these growers operated outside traditional economic systems. They didn’t have 401(k)s or pensions. Their retirement plan was their land and their annual cannabis crop. Now, with prices at historic lows and their physical ability to manage farms diminishing with age, many face an uncertain future.
Some have managed to sell their properties to younger growers or to transplants seeking rural lifestyles, but the collapse in cannabis prices has significantly devalued land throughout the region. Properties that might have sold for millions during the boom years now struggle to find buyers at a fraction of those prices.
Others have attempted to transition to different crops or businesses, with varying degrees of success. There are nascent efforts to develop Humboldt as a cannabis tourism destination, leveraging the region’s storied reputation. Some farms have opened for tours, created farm-stay experiences, or developed educational programs about cannabis cultivation.
Local support networks have emerged as well. Community organizations provide assistance to aging growers, helping them access social services they might have avoided during their years operating in the illegal market. There are food banks specifically serving rural communities and mutual aid networks where neighbors help neighbors.
County and state officials have largely failed to address this looming crisis. The same regulators who created nearly impossible compliance requirements for small farmers have offered little in terms of support for those displaced by the industry’s transformation. There are no pension programs for retired cannabis farmers, no transitional assistance for those whose livelihoods have evaporated.
The situation represents a broader ethical question about legalization: what responsibility do we have to those who built an industry while it was still illegal? These pioneers took significant risks, faced potential imprisonment, and developed the cannabis varieties and cultivation techniques that the legal industry now profits from. Yet they’ve been largely abandoned in the rush toward corporate cannabis.
For communities throughout Humboldt County, the human cost of this transition is impossible to ignore. Empty storefronts in once-thriving towns, properties reclaimed by banks, and elderly residents struggling to survive are the visible manifestations of an economic collapse that could have been mitigated with more thoughtful regulation.
The pioneers of Humboldt’s cannabis industry didn’t just grow a plant—they created a culture and an economy that sustained thousands of people for generations. As that era comes to a close, we must confront difficult questions about what we owe to those who came before and how we might create a more inclusive cannabis industry moving forward.
After reviewing historical accounts like Modic’s and analyzing reports from throughout the region, I’ve come to a sobering conclusion: what we’re witnessing isn’t simply market evolution but rather a deliberate transfer of wealth and opportunity from small independent producers to large corporate interests.
The cannabis industry that sustained generations of Humboldt residents wasn’t perfect. It operated outside the law, sometimes attracted unsavory elements, and certainly had environmental impacts. But it also represented something uniquely American—a decentralized economy where individuals with limited capital could build sustainable livelihoods through their own labor and ingenuity.
The promise of legalization was that it would bring these operations into the light, providing consumer protection while allowing the existing industry to thrive legally. Instead, the regulatory framework that emerged seems almost perfectly designed to eliminate small producers while creating opportunities for well-capitalized newcomers.
This doesn’t appear to be accidental. The excessive regulatory requirements, the high cost of compliance, the limited retail licenses, and the heavy tax burden combine to create insurmountable barriers for small operators. Meanwhile, large multi-state operators can absorb these costs while scaling up production to maintain profitability despite falling prices.
For consumers, this transformation means less diversity in cannabis products, as corporate cultivation favors high-yield strains over the unique varieties developed by Humboldt’s craft growers. For communities, it means the loss of an economic engine that supported everything from schools to social services through the circulation of cannabis dollars.
Most troublingly, the current regulatory regime has failed to achieve even its stated goals. The black market remains robust, suggesting that the legal framework hasn’t created a functioning alternative. Environmental issues persist, both from non-compliant grows and from the massive legal operations that have replaced smaller farms.
Looking forward, there are potential paths to improvement. Reduced tax burdens could help legal operators compete with the black market. Streamlined regulations could make compliance achievable for small farmers. Interstate commerce, if eventually permitted, could open new markets for California’s producers. Craft cannabis designations, similar to wine appellations, could help small farmers distinguish their products in the marketplace.
But for many of Humboldt’s original cannabis families, these changes would come too late. The community and culture they built over decades is already unraveling, a casualty of well-intentioned but fundamentally flawed legalization policies.
The rise and fall of Humboldt’s cannabis industry serves as a cautionary tale for other regions pursuing legalization. It demonstrates that how we legalize matters just as much as whether we legalize. If we truly value diversity, sustainability, and opportunity in the cannabis space, we must create regulatory frameworks that support these values rather than undermining them.
For those of us who care about cannabis culture and the communities built around it, the challenge now is to advocate for policies that preserve what was valuable about the legacy market while addressing its legitimate problems. The alternative—a cannabis industry dominated by the same corporate interests that control so many other sectors of our economy—would represent a profound loss, not just for cannabis consumers but for American culture as a whole.
INSPIRATION:
kymkemp.com/2025/02/21/sohum-history-the-rise-and-fall-of-the-marijuana-industry/
https://kymkemp.com/2025/02/21/sohum-history-the-rise-and-fall-of-the-marijuana-industry/
TRUMP ON CANNABIS THE SECOND TIME AROUND, READ ON…
WHAT DOES TRUMP’S NEW CANNABIS POLICY LOOK LIKE?
Cannabis News
America is Rethinking Marijuana Legalization
Published
4 days agoon
March 1, 2025By
admin
Rethinking Marijuana Legalization: A Response to the National Review
Cannabis legalization has swept across America in waves, creating a patchwork of policies that vary dramatically from state to state. Some jurisdictions embrace full recreational use, others permit medical applications only, while some maintain total prohibition. This inconsistent legal landscape makes it nearly impossible to accurately measure the success or failure of legalization efforts. Without uniform policies and implementations, any cost-benefit analysis becomes murky at best.
In this fragmented environment, opinions about cannabis legalization remain sharply divided. Some celebrate newfound freedoms and opportunities, while others lament perceived social costs and unintended consequences. The National Review recently published an opinion piece questioning whether we should reconsider marijuana legalization altogether, citing several issues they believe undermine the case for legal cannabis.
Today, I’m going to examine these claims with a critical eye. While I agree that we absolutely should “rethink” marijuana legalization, my conclusion differs dramatically from the National Review’s perspective. Rather than retreating from legalization, I believe we need to push forward with more comprehensive reforms that address the legitimate concerns while delivering on the promised benefits.
The current half-measures and regulatory inconsistencies have created a situation where neither prohibitionists nor advocates are satisfied with the outcomes. Only through thoughtful, evidence-based policy adjustments can we realize the full potential of legalization while minimizing downsides. So yes, let’s rethink marijuana legalization – but let’s make sure we’re using all the available data and considering the root causes of any implementation problems.
The National Review piece relies heavily on arguments from Manhattan Institute Senior Fellow Steven Malanga, who suggests legalization has failed to deliver on its promises. The article highlights several key complaints:
-
The pervasive smell of marijuana in public spaces
-
Failure to eliminate black markets
-
Disappointing tax revenue that sometimes requires taxpayer subsidies
-
Increased usage rates contrary to predictions
-
Health concerns, particularly regarding psychosis
-
Perceived connections between cannabis and “social breakdown”
Let’s tackle these points one by one:
The Smell: While cannabis odor can be noticeable, this concern fundamentally misunderstands the concept of liberty in a diverse society. If someone is consuming cannabis in their private residence or in designated areas, their personal choices shouldn’t be criminalized simply because others find the smell unpleasant. Just as we accommodate cigarette smokers in designated areas and don’t ban cooking pungent foods, cannabis consumption can be managed through reasonable time, place, and manner restrictions. The development of cannabis social clubs, similar to cigar lounges, would further localize any odor concerns.
Black Markets:
The persistence of illicit markets isn’t a failure of legalization itself but rather of its incomplete implementation. Black markets thrive precisely because cannabis remains federally illegal, creating banking restrictions, interstate commerce prohibitions, and excessive regulatory burdens that drive up costs for legal operators. States with more reasonable tax structures and fewer arbitrary licensing caps have seen significantly less illicit market activity.
Tax Revenue:
Despite claims to the contrary, legal cannabis has generated billions in tax revenue. Colorado alone has collected over $1.6 billion in marijuana taxes since 2014, funding education, public health, and infrastructure projects. Washington state has generated over $3 billion. While projections may have been overoptimistic in some jurisdictions, this hardly constitutes a failure – it simply indicates a need for more realistic forecasting and better-designed tax structures.
Health Risks:
Cannabis, like any substance, carries certain risks. However, comparative risk assessments consistently show it’s less harmful than legal substances like alcohol and tobacco. Dr. David Nutt’s famous study published in The Lancet ranked alcohol as far more harmful to users and society than cannabis. To focus on potential cannabis risks while ignoring the well-documented devastation of legal substances reveals a problematic double standard.
Usage Patterns:
Youth cannabis use has actually declined or remained stable in many states following legalization, contradicting prohibitionist predictions. Meanwhile, increased use among adults reflects exactly what legalization was designed to accomplish – providing adults with safe, legal access to a substance many find beneficial for relaxation, creativity, or medical symptoms. The decline in youth consumption likely stems partly from reduced novelty and rebellion appeal once cannabis becomes a regulated product rather than a forbidden fruit.
To fully realize the promises of cannabis legalization, we need a more comprehensive approach that addresses the legitimate concerns while removing the artificial constraints that have hampered success.
First and foremost, federal legalization is essential. The current federal prohibition creates unnecessary complications for banking, research, interstate commerce, and taxation. It forces businesses to operate on a cash basis, creating security risks and inefficiencies. It prevents the development of national brands and economies of scale that could drive down consumer costs. And it maintains the Schedule I classification that hampers medical research and perpetuates stigma.
Second, home cultivation rights must be protected. Allowing adults to grow limited amounts of cannabis for personal use provides a safety valve against monopolistic market structures and excessive pricing. It empowers consumers, reduces black market incentives, and recognizes that cannabis is, fundamentally, a plant that people have grown for thousands of years. States that have embraced home grow rights like Michigan and Colorado have seen thriving legal markets alongside personal cultivation.
Third, we need sensible regulatory structures that protect public health without imposing unnecessary burdens. This includes reasonable testing requirements, clear labeling standards, and age restrictions. However, excessive regulations that serve only to limit market participation or drive up costs without clear public health benefits should be eliminated. The current system in many states has created oligopolistic markets where licenses cost millions, shutting out small businesses and social equity applicants.
Fourth, tax policies need recalibration. Excessive taxation, especially when layered across cultivation, processing, and retail levels, drives up consumer prices and fuels black markets. A simple, moderate tax based on potency or sale price would generate revenue while allowing legal markets to compete with illicit operations.
Finally, we need honest education about both the benefits and risks of cannabis. Fear-mongering and exaggeration undermine credibility, while dismissing legitimate concerns is equally problematic. The vast majority of consumers—likely over 95%—will never experience serious adverse effects. However, those with predispositions to certain mental health conditions, particularly adolescents whose brains are still developing, face higher risks that should be clearly communicated.
When we take a clear-eyed look at cannabis legalization’s mixed results, the solution becomes evident: we don’t need less legalization—we need more complete, thoughtful implementation. The problems cited by critics largely stem not from legalization itself, but from the compromised, piecemeal approaches that have characterized policy reform thus far.
Federal legalization with home cultivation rights would strike a devastating blow to illegal markets by allowing interstate commerce, normalizing banking relationships, and recognizing the fundamental right of adults to grow a plant for personal use. The black market doesn’t thrive because legalization failed; it thrives because our current approach is incomplete and inconsistent.
Overtaxing and overregulating legitimate cannabis businesses while maintaining federal prohibition creates the worst of all worlds—high consumer prices, limited access, and continued incentives for illicit operators. We can’t expect the black market to disappear when we’ve designed systems that actively advantage it.
The National Review article gets one thing right—we should indeed rethink marijuana legalization. But instead of retreat, we need to advance toward more coherent, evidence-based policies that truly put “We the People” at the center. Give Americans the freedom to grow their own cannabis, purchase from a diverse marketplace of businesses both small and large, and make personal health decisions without government interference.
Do that, and watch the promises of legalization—reduced black markets, significant tax revenue, controlled access for adults, and diminished criminal influence—finally come to fruition. It’s time to complete the journey we’ve started, not turn back halfway.
TRUMP 2.0 ON LEGAL WEED? READ ON…
WHAT TRUMP’S CANNABIS POLICIES MEAN FOR AMERICA AND THE WORLD!

In a move that has reignited debates about federal drug policy, former President Donald Trump has appointed Terrance Cole as the new head of the Drug Enforcement Administration (DEA). Cole, a veteran DEA official with over two decades of experience, is known for his staunch opposition to marijuana legalization. His appointment signals a return to the Reagan-era “Just Say No” approach to drug enforcement, with Cole publicly linking cannabis use to an increased risk of suicide and schizophrenia, particularly among young users.
The announcement has drawn sharp reactions from both sides of the political aisle, with advocates for cannabis reform expressing concern that Cole’s leadership could roll back progress made in recent years. Meanwhile, proponents of stricter drug enforcement have hailed the appointment as a necessary step to combat what they see as the growing normalization of marijuana in American society.
This article delves into Terrance Cole’s background, his controversial views on cannabis, and what his appointment could mean for the future of marijuana policy in the United States.
A Return to Hardline Drug Policies?
Terrance Cole’s appointment comes at a pivotal time for cannabis policy in the United States. Over the past decade, there has been a seismic shift in public attitudes toward marijuana. As of 2025, 23 states have legalized recreational cannabis use, and 38 states allow medical marijuana. Public opinion polls consistently show that a majority of Americans support federal legalization. Despite this momentum, marijuana remains classified as a Schedule I drug under the Controlled Substances Act—a category reserved for substances with a high potential for abuse and no accepted medical use.
Cole’s nomination appears to signal a departure from the more reform-oriented approach taken by previous administrations. During President Joe Biden’s tenure, there were significant discussions about rescheduling marijuana to a lower classification or even decriminalizing it at the federal level. However, Trump’s decision to appoint Cole suggests that his administration is doubling down on traditional drug enforcement strategies.
In his first public statement following his nomination, Cole said:
”We cannot afford to ignore the science. Marijuana is not the harmless substance that many claim it to be. It poses serious risks to mental health and public safety.”
This rhetoric echoes the anti-drug messaging of the 1980s, when First Lady Nancy Reagan spearheaded the “Just Say No” campaign as part of the broader War on Drugs. Critics argue that such policies disproportionately targeted minority communities and contributed to mass incarceration without effectively addressing substance abuse issues.
Who is Terrance Cole?
Terrance Cole is no stranger to the DEA or its mission. Over his 22-year career with the agency, he rose through the ranks, earning a reputation as a tough-on-crime enforcer. Before his nomination as DEA Administrator, Cole served as Special Agent in Charge of the agency’s Washington Field Division, where he oversaw high-profile operations targeting drug trafficking organizations.
Cole has long been an outspoken critic of marijuana legalization efforts. In 2021, he testified before Congress against proposals to decriminalize cannabis at the federal level. During his testimony, he cited studies suggesting that heavy marijuana use among adolescents could lead to long-term cognitive impairment and an increased likelihood of developing psychosis or schizophrenia.
”The data is clear,” Cole said during his testimony. ”Marijuana today is far more potent than it was 30 years ago. We are not dealing with Woodstock weed anymore; we are dealing with a substance that can have devastating effects on young minds.”
Cole has also linked cannabis use to rising suicide rates among teenagers and young adults. While some studies have explored potential correlations between heavy cannabis use and mental health issues, critics argue that such claims oversimplify complex issues and ignore other contributing factors like socioeconomic conditions and access to mental health care.
The Science Behind Cole’s Claims
Cole’s assertions about marijuana’s risks are not without precedent but remain highly contested within the scientific community. Some research has suggested a potential link between heavy cannabis use and mental health disorders like schizophrenia in individuals predisposed to such conditions. For example:
A 2019 study published in The Lancet Psychiatry found that daily use of high-potency cannabis was associated with an increased risk of psychotic disorders.
Other studies have suggested that early and frequent cannabis use may exacerbate symptoms in individuals already vulnerable to mental health issues.
However, many experts caution against drawing causal conclusions from these findings. Dr. Susan Weiss, director of the ”ivision of Extramural Research at the National Institute on Drug Abuse (NIDA), has stated:
”While there is evidence of an association between cannabis use and certain mental health outcomes, it is important to consider other variables that may contribute to these risks.”
Moreover, proponents of legalization argue that regulating marijuana can mitigate some of these risks by ensuring product safety and providing education about responsible use.
Implications for Federal Marijuana Policy
Cole’s appointment could have far-reaching consequences for federal marijuana policy. As head of the DEA, he will play a key role in determining how federal law enforcement approaches cannabis-related offenses. This includes decisions about whether to prioritize crackdowns on state-legal cannabis businesses or focus resources on other drug enforcement efforts.
One immediate concern among advocates is how Cole’s leadership might impact efforts to reschedule or deschedule marijuana under federal law. In October 2022, President Biden directed federal agencies to review marijuana’s classification as a Schedule I drug—a move widely seen as a step toward reform. However, with Cole at the helm of the DEA, such efforts could face significant resistance.
Kevin Sabet, president of Smart Approaches to Marijuana (SAM), praised Cole’s appointment as a victory for public health:
”Terrance Cole understands that we cannot sacrifice our youth’s well-being on the altar of Big Marijuana profits.”
On the other hand, organizations like NORML (National Organization for the Reform of Marijuana Laws) have expressed alarm over what they see as a regressive turn in federal policy. In a statement following Cole’s nomination, NORML Executive Director Erik Altieri said:
”This appointment represents an outdated approach to drug policy that ignores decades of progress and overwhelming public support for legalization.”
State vs. Federal Tensions
Cole’s hardline stance could exacerbate tensions between state governments that have legalized marijuana and federal authorities tasked with enforcing prohibition laws. While Congress passed legislation in 2023 protecting state-legal cannabis businesses from federal interference, these protections are not permanent and could be revisited under new leadership.
In states like Colorado and California—where legal cannabis industries generate billions in revenue annually—there is growing concern about how aggressive federal enforcement might disrupt local economies. Additionally, medical marijuana patients who rely on cannabis for conditions like chronic pain or epilepsy worry about potential restrictions on access.
The Broader Debate: Public Safety vs. Personal Freedom
At its core, Cole’s appointment reignites broader debates about how society should balance public safety concerns with individual freedoms when it comes to drug use. Supporters of stricter enforcement argue that normalizing marijuana sends mixed messages about its risks—particularly to young people—and undermines efforts to address substance abuse more broadly.
Opponents counter that criminalizing cannabis does more harm than good by perpetuating systemic inequalities and diverting resources away from addressing more pressing public health crises like opioid addiction.
Dr. Ethan Russo, a neurologist and prominent cannabis researcher, argues:
”We need policies grounded in science rather than fear-mongering rhetoric. Demonizing cannabis ignores its potential benefits while failing to address legitimate concerns about misuse.”
Conclusion
Terrance Cole’s appointment as DEA Administrator marks a significant shift in federal drug policy under former President Donald Trump’s administration. With his “Just Say No”-style rhetoric and firm opposition to marijuana legalization, Cole represents a return to more traditional approaches to drug enforcement—ones that many hoped were relics of the past.
As debates over cannabis reform continue to unfold at both state and federal levels, one thing is clear: Terrance Cole’s leadership will be closely watched by advocates on all sides of this contentious issue. Whether his tenure will lead to meaningful progress or further polarization remains an open question—but its impact on America’s evolving relationship with marijuana is likely to be profound.
THE DEA ON HEMP AND MARIJUANA, READ ON…

Karma Koala Podcast 238: Daniel Shortt Launches New Firm With Partner Perry Salzhauer In Pacific NW

Trump invites former cannabis prisoner to speech, but doesn’t mention cannabis (Newsletter: February 5, 2025)

Buddha Chief raises vibrations at new Housing Works dispensary in NoMad

3 best THCA vape carts of 2025 by Leafly

From client to co-founder, Storz & Bickel executive on US tour to drum up cannabis business

UNDERSTANDING CANNABIS AND CANNABINOIDS (THC and CBD)

The Rise and Fall of the Cannabis Industry

High Stakes and High Demand: Will Las Vegas Finally Allow Cannabis Near Casinos?

Cannabis Tourism in 2025: Destinations, Trends, and Tips

The Rise of Cannabis in Florida

Distressed Cannabis Business Takeaways – Canna Law Blog™

United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)

What you Need to Know

Drug Testing for Marijuana – The Joint Blog

NCIA Write About Their Equity Scholarship Program

It has been a wild news week – here’s how CBD and weed can help you relax

Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022

A new April 20 cannabis contest includes a $40,000 purse

Your Go-To Source for Cannabis Logos and Designs

UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing1 year ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse